Spruce Biosciences SPRB
NASDAQ SPRB
$48.61 +1.34 (+2.83%)
As of: Sep 30, 2026 · 10:25 AM EDT

Spruce Biosciences (SPRB) Total Non-Current Liabilities (2019 - 2026)

Updated

Spruce Biosciences' Total Non-Current Liabilities came in at $15.8 million for Q2 2026, up 82.9% from $8.64 million a year earlier but down 10.1% from the prior quarter.

Analysis

Spruce Biosciences (SPRB) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Spruce Biosciences' Total Non-Current Liabilities was $10.51 million, down 34.8% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $16.11 million in FY2024 (-40.8%), $27.2 million in FY2023 (+60.0%), $17 million in FY2022 (+13.0%) and $15.04 million in FY2021 (+12.8%).
  • The five-year range for quarterly Total Non-Current Liabilities is $8.64 million (Q2 2025) to $30.94 million (Q1 2023).
  • Year-over-year, Total Non-Current Liabilities increased in two of the last eight quarters, with an average decline of 16.1%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q1 2023 (growth of 111.2%), and the weakest in Q3 2021 (a decline of 88.2%).
  • Business Quant data shows SPRB's Total Non-Current Liabilities at $17.58 million (Q1 2026), $10.51 million (Q4 2025) and $9.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Spruce Biosciences 130.79 Mn 130.79 Mn - 15.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.80 Mn
Mar 31, 2026 17.58 Mn
Dec 31, 2025 10.51 Mn
Sep 30, 2025 9.93 Mn
Jun 30, 2025 8.64 Mn
Mar 31, 2025 16.33 Mn
Dec 31, 2024 16.11 Mn
Sep 30, 2024 13.19 Mn
Jun 30, 2024 16.09 Mn
Mar 31, 2024 20.67 Mn
Dec 31, 2023 27.20 Mn
Sep 30, 2023 27.38 Mn
Jun 30, 2023 29.20 Mn
Mar 31, 2023 30.94 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 16.68 Mn
Jun 30, 2022 15.28 Mn
Mar 31, 2022 14.65 Mn
Dec 31, 2021 15.04 Mn
Sep 30, 2021 15.32 Mn
API Access

Spruce Biosciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SPRB&period=max&api_key=YOUR_API_KEY